Search research articles
Contact Us
Filters
Showing results (1-10 of 32) with videos related to
Page
of 4
Sort By:
Transplantation
|
April 30, 2003
A phase III prospective, randomized study to evaluate concentration-controlled sirolimus (rapamune) with cyclosporine dose minimization or elimination at six months in de novo renal allograft recipients
Keshwar Baboolal
Nature Reviews. Nephrology
|
May 26, 2010
Risk factors for new-onset diabetes after kidney transplantation
Adnan Sharif, Keshwar Baboolal
Peritoneal Dialysis International : Journal of the International Society for Peritoneal Dialysis
|
March 3, 2011
Update on dialysis economics in the UK
Adnan Sharif, Keshwar Baboolal
Nature Reviews. Nephrology
|
November 16, 2011
Complications associated with new-onset diabetes after kidney transplantation
Adnan Sharif, Keshwar Baboolal
Journal of the American Society of Nephrology : JASN
|
February 6, 2010
Diagnostic application of the A(1c) assay in renal disease
Adnan Sharif, Keshwar Baboolal
Transplantation
|
October 3, 2002
Obesity and transplantation
W Adam Jurewicz, Keshwar Baboolal
Transplantation
|
February 28, 2008
Influence of lifestyle modification in renal transplant recipients with postprandial hyperglycemia
Adnan Sharif, Richard Moore, Keshwar Baboolal
Yonsei Medical Journal
|
January 1, 2005
Post transplant diabetes mellitus after renal transplantation: the emerging clinical challenge
Vinod Ravindran, Keshwar Baboolal, Richard Moore
Transplantation
|
January 2, 2007
The use of oral glucose tolerance tests to risk stratify for new-onset diabetes after transplantation: An underdiagnosed phenomenon
Adnan Sharif, Richard H Moore, Keshwar Baboolal
Transplantation
|
January 9, 2014
Long-term progression of abnormal glucose tolerance and its relationship with the metabolic syndrome after kidney transplantation
Pramod Nagaraja, Adnan Sharif, Vinod Ravindran, et al.
Page
of 4
Search research articles
Search
Showing results (1-10 of 32) with videos related to
Sort By:
Page
of 4
Transplantation
|
April 30, 2003
A phase III prospective, randomized study to evaluate concentration-controlled sirolimus (rapamune) with cyclosporine dose minimization or elimination at six months in de novo renal allograft recipients
Keshwar Baboolal
Nature Reviews. Nephrology
|
May 26, 2010
Risk factors for new-onset diabetes after kidney transplantation
Adnan Sharif, Keshwar Baboolal
Peritoneal Dialysis International : Journal of the International Society for Peritoneal Dialysis
|
March 3, 2011
Update on dialysis economics in the UK
Adnan Sharif, Keshwar Baboolal
Nature Reviews. Nephrology
|
November 16, 2011
Complications associated with new-onset diabetes after kidney transplantation
Adnan Sharif, Keshwar Baboolal
Journal of the American Society of Nephrology : JASN
|
February 6, 2010
Diagnostic application of the A(1c) assay in renal disease
Adnan Sharif, Keshwar Baboolal
Transplantation
|
October 3, 2002
Obesity and transplantation
W Adam Jurewicz, Keshwar Baboolal
Transplantation
|
February 28, 2008
Influence of lifestyle modification in renal transplant recipients with postprandial hyperglycemia
Adnan Sharif, Richard Moore, Keshwar Baboolal
Yonsei Medical Journal
|
January 1, 2005
Post transplant diabetes mellitus after renal transplantation: the emerging clinical challenge
Vinod Ravindran, Keshwar Baboolal, Richard Moore
Transplantation
|
January 2, 2007
The use of oral glucose tolerance tests to risk stratify for new-onset diabetes after transplantation: An underdiagnosed phenomenon
Adnan Sharif, Richard H Moore, Keshwar Baboolal
Transplantation
|
January 9, 2014
Long-term progression of abnormal glucose tolerance and its relationship with the metabolic syndrome after kidney transplantation
Pramod Nagaraja, Adnan Sharif, Vinod Ravindran, et al.
Page
of 4